医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Potential impact of controlling risk factors on future liver cancer deaths in China

摘要Objective:This study aims to quantify the potential impact of controlling major risk factors on liver cancer deaths in China from 2021 to 2050 under various intervention scenarios.Methods:We developed a macro-level simulation model based on comparative risk assessment to estimate population attributable fractions and avoidable liver cancer deaths.Risk factor prevalence data were obtained from national surveys and epidemiological estimates.Three intervention scenarios for each risk factor were projected:elimination(Scenario 1),ambitious reduction(Scenario 2),and manageable targets aligned with national/global goals(Scenario 3).The impact of secondary prevention through liver cancer screening at different coverage was evaluated.Results:Between 2021 and 2050,liver cancer deaths in China are projected to reach 9.44 million in males and 4.29 million in females.Eliminating hepatitis B virus and hepatitis C virus could prevent 65.62%(57.47%-73.77%)and 28.47%(24.93%-32.00%)of liver cancer deaths,respectively.Achieving manageable targets in reducing the prevalence of smoking and alcohol drinking could prevent 6.57%(5.75%-7.38%)and 0.85%(0.75%-0.96%)of liver cancer deaths,with a more pronounced effect observed in males.Eliminating high body mass index(BMI)could avert 45,000 male and 25,000 female deaths annually by 2050,while diabetes elimination could prevent 60,000 male and 21,000 female deaths.Secondary prevention through liver cancer screening with 80%coverage could reduce liver cancer deaths by 3.59%(3.14%-4.04%)for the total population.Combining all interventions under Scenario 1 could prevent up to 88.39%(76.65%-99.81%)of male and 77.80%(67.42%-87.88%)of female liver cancer deaths by 2050.Conclusions:Comprehensive risk factor control could prevent over 80%of liver cancer deaths in China by 2050.Secondary prevention through screening may offer modest additional benefits.These findings provide strong quantitative support for targeted,evidence-based interventions and underscore the need for policy action to address key risk factors.

更多
广告
作者 Mengdi Cao [1] Yi Teng [1] Qianru Li [1] Nuopei Tan [1] Jiachen Wang [1] Tingting Zuo [1] Tianyi Li [1] Yuanjie Zheng [1] Changfa Xia [1] Wanqing Chen [1] 学术成果认领
作者单位 Office of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China [1]
栏目名称
DOI 10.21147/j.issn.1000-9604.2025.03.08
发布时间 2025-08-11(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览1
  • 下载0
中国癌症研究(英文版)

中国癌症研究(英文版)

2025年37卷3期

中插45,390-403,中插46-中插47页

SCIMEDLINEISTICCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷